GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, and the GIP/GLP-1 dual agonist tirzepatide, act on appetite regulation, satiety, and gastric emptying
While there is some promising evidence for the use of omega-3 fatty acids for major depression and bipolar disorder, additional trials that account for dietary omega-3 intake, changes in red blood cell PUFA concentrations, the ratio of EPA:DHA provided, and co-treatment with medications are necessary
(2013), form one of the larger published datasets among fragment peptides in this category
Journal of visualized experiments : JoVE (128)
Beyond stroke and vascular dementia, the evidence thins from Cochrane reviews into manufacturer-adjacent meta-analyses
Knowing this profile is the difference between informed decision-making and trial-and-error